Cargando…
Treatment with astragaloside IV reduced blood glucose, regulated blood lipids, and protected liver function in diabetic rats
OBJECTIVES: To investigate the effects of astragaloside IV on blood glucose, blood lipids, and liver function in diabetic rats. METHODS: Fifty diabetic rats were randomly placed into five groups (n = 10 each): the diabetes mellitus (DM) group received intragastric saline, the metformin hydrochloride...
Autor principal: | Han, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166410/ https://www.ncbi.nlm.nih.gov/pubmed/33706619 http://dx.doi.org/10.1177/0300060519841165 |
Ejemplares similares
-
Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice
por: Song, Gaofeng, et al.
Publicado: (2018) -
Aerobic training and L-arginine supplement attenuates myocardial infarction-induced kidney and liver injury in rats via reduced oxidative stress
por: Ranjbar, Kamal, et al.
Publicado: (2018) -
Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009) -
Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2014) -
Protective role of arnebin-1 in rats with nonalcoholic fatty liver
disease
por: Yang, Weijia, et al.
Publicado: (2019)